Clinical and design update on the development and testing of a one-piece, bifurcated, polytetrafluoroethylene endovascular graft for abdominal aorticaneurysm exclusion: The Endologix device

Continued success and expanding use of endovascular prostheses to manage ao rtic aneurysms has encouraged development of novel prototypes that offer ad vantages for low-profile delivery of durable devices. The Endologix device, currently being acquired by CR Bard, Incorporated, is a new, one-piece sel f-expanding polytetrafluoroethylene pros thesis that offers all alternative to current modular and fabric devices. Although only preliminary U.S. and expanding European experiences are available, the unique features of this p rosthesis appear to offer an appealing alternative.